<DOC>
	<DOCNO>NCT02273518</DOCNO>
	<brief_summary>Comparative pharmacokinetics dipyridamole two new formulation Asasantin ER compare present commercial formulation</brief_summary>
	<brief_title>Study Compare Pharmacokinetics Dipyridamole Three Different Asasantin Extended Release ( ER ) Formulations Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Aspirin , Dipyridamole Drug Combination</mesh_term>
	<criteria>All participant study healthy male female , range 21 50 year age within ± 20 % normal weight ( BrocaIndex ) Prior admission study volunteer give , accordance good clinical practice ( GCP ) local legislation , write informed consent Subsequently subject medical history take receive complete medical examination ( incl . blood pressure pulse rate measurement ) well 12lead ECG Hematopoietic , hepatic renal function test carry laboratory The subject fast 12 hour collection specimens laboratory evaluation The mentioned examination perform within 14 day first administration test substance Volunteers exclude study result medical examination laboratory test judge clinical investigator differ significantly normal clinical value Subjects known gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Subjects diseases central nervous system ( epilepsy ) psychiatric neurological disorder History orthostatic hypotension , faint spell blackouts Subjects chronic relevant acute infection Subjects allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Volunteers take drug long halflife ( ≥ 24 hour ) within one month less ten halflives respective drug enrolment study Volunteers receive drug might influence result trial week previous enrolment study Volunteers participate another study investigational drug within last two month precede study Volunteers unable refrain smoking study day Volunteers smoke than10 cigarette ( equivalent ) per day Volunteers drink 60 g alcohol per day Volunteers dependent drug Volunteers donate blood ( ≥ 100 mL ) within last four week Volunteers participate excessive physical activity within last week study ( e.g . competitive sport ) Volunteers suffer disease abnormality clinical relevance History hemorrhagic diatheses History gastrointestinal ulcer , perforation bleed History bronchial asthma History glucose6phosphate dehydrogenase ( G6PD ) deficiency Female subject : Pregnancy Positive pregnancy test No adequate contraception ( adequate contraception e.g . sterilization , intrauterine device ( IUD ) , oral contraceptive ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>